Aryzta


Top-line weakness, bottom-line improvements

08/10/19 -"Mixed set of FY19 results, as the top line was weak but profitability improved, at last! North American revenue remains the main issue. "

Pages
38
Language
English
Published on
08/10/19
You may also be interested by these reports :
18/10/19
While Q2 was expected to see acceleration, the group reported -3.6% organic sales growth (-4% in Q2, est. -2.7%) due to technical factors and Group ...

18/10/19
While traditional tobacco companies proved less and less convincing about alternative strategies since mid-2017, Swedish Match (Buy, Sweden) stood ...

18/10/19
Danone reported Q3 sales figures below consensus expectations and now targets lower full-year sales growth from 3% to between 2.5% and 3%. The ...

17/10/19
Nestle reported 9m results in line with the consensus estimates. Growth was strongly supported by the significant performance in the USA and Purina ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO